Insmed
INSM
#1118
Rank
โ‚น2.012 T
Marketcap
โ‚น9,286
Share price
3.07%
Change (1 day)
6.91%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น129.31 Billion

According to Insmed's latest financial reports the company's total liabilities are โ‚น129.31 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น136.95 B-8.24%
2024-12-31โ‚น149.25 B7.89%
2023-12-31โ‚น138.33 B6.59%
2022-12-31โ‚น129.79 B109.33%
2021-12-31โ‚น62.00 B62.96%
2020-12-31โ‚น38.04 B11.02%
2019-12-31โ‚น34.27 B23.69%
2018-12-31โ‚น27.70 B329.73%
2017-12-31โ‚น6.44 B13.68%
2016-12-31โ‚น5.67 B90.28%
2015-12-31โ‚น2.98 B5.4%
2014-12-31โ‚น2.82 B38%
2013-12-31โ‚น2.04 B14.54%
2012-12-31โ‚น1.78 B507.68%
2011-12-31โ‚น0.29 B92.02%
2010-12-31โ‚น0.15 B18.83%
2009-12-31โ‚น0.12 B-64.59%
2008-12-31โ‚น0.36 B15.89%
2007-12-31โ‚น0.31 B-50.93%
2006-12-31โ‚น0.64 B15.39%
2005-12-31โ‚น0.55 B122.01%
2004-12-31โ‚น0.25 B52.95%
2003-12-31โ‚น0.16 B-29.83%
2002-12-31โ‚น0.23 B-59.45%
2001-12-31โ‚น0.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚น7.508 T 5,706.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น3.098 T 2,295.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น671.81 B 419.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น157.88 B 22.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น50.89 B-60.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น113.86 B-11.95%๐Ÿ‡บ๐Ÿ‡ธ USA